Macrophages in skin injury and repair.

[1]  D. Hume,et al.  An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation. , 2010, Blood.

[2]  Christiana Ruhrberg,et al.  Tissue macrophages act as cellular chaperones for vascular anastomosis downstream of VEGF-mediated endothelial tip cell induction. , 2010, Blood.

[3]  P. Carmeliet,et al.  Blood-vessel formation: Bridges that guide and unite , 2010, Nature.

[4]  J. Roes,et al.  Differential Roles of Macrophages in Diverse Phases of Skin Repair , 2010, The Journal of Immunology.

[5]  M. Blombäck,et al.  The direct thrombin inhibitors (argatroban, bivalirudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis , 2010, Thrombosis and Haemostasis.

[6]  Olivier Levillain,et al.  Macrophage Plasticity in Experimental Atherosclerosis , 2010, PloS one.

[7]  R. Stout.  Editorial: Macrophage functional phenotypes: no alternatives in dermal wound healing? , 2010, Journal of leukocyte biology.

[8]  J. Albina,et al.  The phenotype of murine wound macrophages , 2010, Journal of leukocyte biology.

[9]  T. Koh,et al.  Selective and specific macrophage ablation is detrimental to wound healing in mice. , 2009, The American journal of pathology.

[10]  J. Suttles,et al.  Functional plasticity of macrophages: in situ reprogramming of tumor‐associated macrophages , 2009, Journal of leukocyte biology.

[11]  E. Pamer,et al.  Dispensable But Not Irrelevant , 2009, Science.

[12]  P. Libby,et al.  Identification of Splenic Reservoir Monocytes and Their Deployment to Inflammatory Sites , 2009, Science.

[13]  N. Mirancea,et al.  Basement membranes in skin: unique matrix structures with diverse functions? , 2009, Histochemistry and Cell Biology.

[14]  P. V. van Zuijlen,et al.  Potential cellular and molecular causes of hypertrophic scar formation. , 2009, Burns : journal of the International Society for Burn Injuries.

[15]  J. Edwards,et al.  Exploring the full spectrum of macrophage activation , 2008, Nature Reviews Immunology.

[16]  Antonio Duarte,et al.  Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation , 2008, Nature.

[17]  J. Jester,et al.  Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing α‐smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  P. Murphy,et al.  Chemokine Receptor CX3CR1 Mediates Skin Wound Healing by Promoting Macrophage and Fibroblast Accumulation and Function1 , 2008, The Journal of Immunology.

[19]  T. Wynn,et al.  Cellular and molecular mechanisms of fibrosis , 2008, The Journal of pathology.

[20]  T. Krieg,et al.  Inflammation in wound repair: molecular and cellular mechanisms. , 2007, The Journal of investigative dermatology.

[21]  M. Delehanty,et al.  Polarized Th2 cytokine production in patients with hypertrophic scar following thermal injury. , 2006, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[22]  D. Dormont,et al.  Macrophage activation switching: an asset for the resolution of inflammation , 2005, Clinical and experimental immunology.

[23]  Paul Martin,et al.  Inflammatory cells during wound repair: the good, the bad and the ugly. , 2005, Trends in cell biology.

[24]  C. Jobin,et al.  Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. , 2005, The American journal of pathology.

[25]  C. Baum,et al.  Normal Cutaneous Wound Healing: Clinical Correlation with Cellular and Molecular Events , 2005, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[26]  M. Santoro,et al.  Cellular and molecular facets of keratinocyte reepithelization during wound healing. , 2005, Experimental cell research.

[27]  G. Coukos,et al.  Vascular leukocytes contribute to tumor vascularization. , 2005, Blood.

[28]  M. Aurrand-Lions,et al.  Adhesion mechanisms regulating the migration of monocytes , 2004, Nature Reviews Immunology.

[29]  L. V. Williams,et al.  Tissue repair and the dynamics of the extracellular matrix. , 2004, The international journal of biochemistry & cell biology.

[30]  R. Kalluri,et al.  Epithelial-mesenchymal transition and its implications for fibrosis. , 2003, The Journal of clinical investigation.

[31]  S. Werner,et al.  Regulation of wound healing by growth factors and cytokines. , 2003, Physiological reviews.

[32]  K. Flanders,et al.  Smad3: A Key Player in Pathogenetic Mechanisms Dependent on TGF‐β , 2003, Annals of the New York Academy of Sciences.

[33]  Dong-Seok Kim,et al.  Sphingosine-1-phosphate and its potentially paradoxical effects on critical parameters of cutaneous wound healing. , 2003, The Journal of investigative dermatology.

[34]  L. DiPietro,et al.  Accelerated wound closure in neutrophil‐depleted mice , 2003, Journal of leukocyte biology.

[35]  D. Mosser,et al.  The many faces of macrophage activation , 2003, Journal of leukocyte biology.

[36]  P. Allavena,et al.  Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. , 2002, Trends in immunology.

[37]  T. Ling,et al.  Synthetic TGF‐β antagonist accelerates wound healing and reduces scarring , 2002 .

[38]  P. Bongrand,et al.  The IL-6-Soluble IL-6Rα Autocrine Loop of Endothelial Activation as an Intermediate Between Acute and Chronic Inflammation: an Experimental Model Involving Thrombin , 2001, The Journal of Immunology.

[39]  W. Timens,et al.  Keratinocyte‐derived growth factors play a role in the formation of hypertrophic scars , 2001, The Journal of pathology.

[40]  S. Goerdt,et al.  Alternatively Activated Macrophages Differentially Express Fibronectin and Its Splice Variants and the Extracellular Matrix Protein βIG‐H3 , 2001, Scandinavian journal of immunology.

[41]  V. Kähäri,et al.  Matrix metalloproteinases in wound repair (review). , 2000, International journal of molecular medicine.

[42]  A. Richmond,et al.  Delayed wound healing in CXCR2 knockout mice. , 2000, The Journal of investigative dermatology.

[43]  A. Ghahary,et al.  Hypertrophic scar tissues and fibroblasts produce more transforming growth factor‐β1 mRNA and protein than normal skin and cells , 2000, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[44]  J. Pfeilschifter,et al.  Large induction of the chemotactic cytokine RANTES during cutaneous wound repair: a regulatory role for nitric oxide in keratinocyte-derived RANTES expression. , 2000, The Biochemical journal.

[45]  M Kon,et al.  On the nature of hypertrophic scars and keloids: a review. , 1999, Plastic and reconstructive surgery.

[46]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[47]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[48]  P. Cullen,et al.  Human macrophages synthesize type VIII collagen in vitro and in the atherosclerotic plaque , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[49]  S. Goerdt,et al.  Other functions, other genes: alternative activation of antigen-presenting cells. , 1999, Immunity.

[50]  Sathyanarayana,et al.  Normoxic wound fluid contains high levels of vascular endothelial growth factor. , 1998, Annals of surgery.

[51]  S. Werner,et al.  Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. , 1998, Experimental cell research.

[52]  N. Thatcher,et al.  G- and GM-CSF. , 1998, International journal of antimicrobial agents.

[53]  S. Rafii,et al.  Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[54]  S. Werner,et al.  Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid-treated mice. , 1996, Cytokine.

[55]  C. Jun,et al.  Control of scarring in adult wounds using antisense transforming growth factor‐β1 oligodeoxynucleotides , 1996, Immunology and cell biology.

[56]  J. Erusalimsky,et al.  Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells. Synergistic interaction with hypoxia. , 1995, Circulation.

[57]  M. Longaker,et al.  Regulation of Vascular Endothelial Growth Factor Expression in Cultured Keratinocytes. , 1995, The Journal of Biological Chemistry.

[58]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.

[59]  D. Foreman,et al.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.

[60]  S. Bunting,et al.  The Regulation of Blood Vessel Growth by Vascular Endothelial Growth Factor , 1995, Annals of the New York Academy of Sciences.

[61]  T. Ley,et al.  Cloning and characterization of a unique elastolytic metalloproteinase produced by human alveolar macrophages. , 1993, The Journal of biological chemistry.

[62]  J. Maraganore.  Thrombin, Thrombin Inhibitors, and the Arterial Thrombotic Process , 1993, Thrombosis and Haemostasis.

[63]  E. Keshet,et al.  Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.

[64]  B. Berse,et al.  Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. , 1992, Molecular biology of the cell.

[65]  K. Bost,et al.  Substance P production by P388D1 macrophages: a possible autocrine function for this neuropeptide. , 1990, Immunology.

[66]  T. K. Hunt,et al.  Oxygen tension regulates the expression of angiogenesis factor by macrophages. , 1983, Science.

[67]  T. K. Hunt,et al.  Stimulation of wound blood vessel growth by wound macrophages. , 1979, The Journal of surgical research.

[68]  T Scott-Burden,et al.  Activated macrophages digest the extracellular matrix proteins produced by cultured cells. , 1979, Biochemical and biophysical research communications.

[69]  T. K. Hunt,et al.  The proliferative response in vitro of vascular endothelial and smooth muscle cells exposed to wound fluids and macrophages , 1978, Journal of cellular physiology.

[70]  Z. Cohn,et al.  INDUCTION OF MACROPHAGE PLASMINOGEN ACTIVATOR BY ENDOTOXIN STIMULATION AND PHAGOCYTOSIS , 1974, The Journal of experimental medicine.

[71]  R. Ross,et al.  The neutrophilic leukocyte in wound repair a study with antineutrophil serum. , 1972, The Journal of clinical investigation.

[72]  R. Ross,et al.  WOUND HEALING AND COLLAGEN FORMATION , 1970, The Journal of cell biology.

[73]  B. de Crombrugghe,et al.  Dermal transforming growth factor-beta responsiveness mediates wound contraction and epithelial closure. , 2010, The American journal of pathology.

[74]  Napoleone Ferrara,et al.  The role of vascular endothelial growth factor in pathological angiogenesis , 2004, Breast Cancer Research and Treatment.

[75]  J. Duffield.  The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.

[76]  M. Longaker,et al.  Fetal Wound Healing: Current Biology , 2003, World Journal of Surgery.

[77]  J. Duffield.  The inflammatory macrophage , 2003 .

[78]  S. Gordon.  Alternative activation of macrophages , 2003, Nature Reviews Immunology.

[79]  V. V. van Hinsbergh,et al.  Role of fibrin and plasminogen activators in repair-associated angiogenesis: in vitro studies with human endothelial cells. , 1997, EXS.

[80]  S. O'Kane,et al.  Transforming growth factor βs and wound healing , 1997 .

[81]  T. M. Doherty.  T-cell regulation of macrophage function. , 1995, Current opinion in immunology.

[82]  E. Kovacs,et al.  Modulation of JE/MCP-1 expression in dermal wound repair. , 1995, The American journal of pathology.

[83]  R. Ross,et al.  The role of the macrophage in wound repair. A study with hydrocortisone and antimacrophage serum. , 1975, The American journal of pathology.